L. J. Goldstein
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102
.
Journal of Clinical Oncology.
2018
Contact
full name
L. J.
Goldstein
Quick Info
Collaboration
Co-author network
Map of science
Picked up by
6
news outlets
Referenced in
1
policy sources
Posted by
17
X users
Referenced in
1
patents
On
1
Facebook pages
215
readers on Mendeley
See more details